Evidence map›Paper›PMID 31031602›Full record

ArticleFrontiers in integrative neuroscience2019

Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson's Disease in Male Rats.

Artem Minalyan, Lilit Gabrielyan, Claudio Pietra, Yvette Taché, Lixin Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in integrative neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. The Emerging Role of Neuropeptides in Parkinson's Disease.Frontiers in aging neuroscience · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Artem MinalyanVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
Lilit GabrielyanVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
Claudio PietraHelsinn SA Lugano, Lugano, Switzerland.
Yvette TachéVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
Lixin WangVeterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
University of California, Los Angeles · USVA Greater Los Angeles Healthcare System · USHelsinn (Switzerland) · CH

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
NIDDK NIH HHS P30 DK041301RRD VA I01 RX001685
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

6-hydroxydopaminebody compositiondefecationghrelin agonistratwater intake

Identifiers

PMID31031602
PMCPMC6474391
OpenAlexW2937765603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.